Federal Register of Legislation - Australian Government

Primary content

Specifications as made
The specification has the effect of specifying, for the purposes of paragraph 3(5)(ca) of the Act, advisory statements that are required to be set out on the label of medicines that are included in a class of medicines prescribed by the regulations.
Administered by: Health
Registered 02 Dec 2015
Tabling HistoryDate
Tabled HR03-Dec-2015
Tabled Senate02-Feb-2016
Date of repeal 01 Jul 2017
Repealed by Medicines Advisory Statements Specification 2017
Help with file formats Help with file formats
Legislative Instrument
F2015L01916 : Authoritative PDF Document : 2MB Primary Document Icon F2015L01916 : ZIP Document : 0.4MB
196 pages

Explanatory Statement
F2015L01916ES : PDF Document : 0.5MB Primary Document Icon F2015L01916ES : ZIP Document : 29KB
6 pages